US investigating bribery involving GlaxoSmithKline in China

US authorities are investigating British drugmaker GlaxoSmithKline for violations of US anti-bribery laws in China after Chinese government officials accused the company of bribing doctors, three sources familiar with the probe said last week.

via Business feed http://www.scmp.com/news/china/article/1305923/us-investigating-bribery-involving-glaxosmithkline-china